What is the Price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients

Hematological Oncology

Volumn 25, Issue 4, 2007, Pages 178-183

  Zsófia, Miltényi ^a   Katalin, Keresztes ^a   Judit, Végh ^a   György, Székely ^a   Árpád, Illés ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Hodgkin's lymphoma; Late complications; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LONG TERM CARE; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN DEFECT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HODGKIN DISEASE; HUMANS; HUNGARY; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL RATE; TIME FACTORS;

EID: 37649025339     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.824     Document Type: Article

References (30)

1. Diehl V, Mauch P, Connors JM. Hodgkin's lymphoma. Hematology Proceedings of The American Society of Hematology 1999; 270-289.
2. Bookman MA, Longo DL, Young RC. Late complications of curative treatment Hodgkin's disease. JAMA 1988; 5: 680-683.
3. Hancock SL, Hoppe RT. Long term complications of treatment and causes of mortality after HD. Semin Radiat Oncol 1996; 6: 225-242.
4. Carbone PP, Kaplan HS, Musshoff K. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
5. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630-1636.
6. Lukes RJ, Craver LF, Hall TC. Report of the nomenclatura committee. Cancer Res 1966; 26: 1311.
7. Connors JM, Noordijk EM, Horning SJ. Hodgkin's lymphoma: basing the treatment on the evidence. Hematology American Society Hematological Education Program 2001; 178-193.
8. Henry-Amar M, Somers R. Survival outcome after Hodgkin's disease: a report from the International Data Base on Hodgkin's disease. Semin Oncol 1990; 17: 758-768.
9. Cosset JM, Henry-Amar M, Girinski T, Malaise E, Dupouy N, Dutreix J. Late toxicity of radiotherapy in Hodgkin's disease. Acta Oncol 1988; 27: 123-129.
10. Végh J, Vadász Gy, Miltényi Zs, Soltész P, Tizedes F, Illés Á. Valvulopathia elofordulása tartósan komplett remisszióban lévo Hodgkin-kóros betegeknél. Magy Onkol 2002; 46: 357-360.
11. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996; 27: 766-773.
12. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993; 11: 1208-1215.
13. King V, Constine LS, Clark D, et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1996; 36: 881-889.
14. Piovaccari G, Ferretti RM, Prati F, et al. Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up. Int J Cardiol 1995; 49: 39-43.
15. Reber D, Birnbaum DE, Tollenare P. Heart diseases following mediastinal irradiation: surgical management. Eur J Cardiothorac Surg 1995; 9: 202-205.
16. Garling B, Gottdiener J, Borer JS. Cardiovascular complications of the treatment of Hodgkin's disease. In Hodgkin's Disease: The Consequenses of Survival (1st edn), Lacher JM, Redman JR (eds). Lea and Febiger Ltd: Philadelphia, London, 1990; 267-295.
17. Miltényi Zs, Keresztes K, Garai I, et al. Radiation-in duced coronary artery disease in Hodgkin's disease. Card Rad Med 2004; 5: 38-43.
18. Tarbell NJ, Mauch P, Hellman S. Pulmonary complications of Hodgkin's disease treatment: radiation pneumonitis, fibrosis, and the effect of cytotoxic drugs. In Hodgkin's Disease: The Consequenses of Survival (1st edn), Lacher JM, Redman JR (eds). Lea and Febiger Ltd: Philadelphia, London, 1990; 296-305.
19. Healy JC, Shafford EA, Reznek RH. Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin's disease. Br J Radiol 1996; 69: 617-623.
20. Redman JR, Bajorunas DR. Therapy-related thyroid and parathyroid dysfunction in patients with Hodgkin's disease. In Hodgkin's Disease: The Consequenses of Survival (1st edn). Lacher JM, Redman JR (eds). Lea and Febiger Ltd: Philadelphia-London, 1990; 222-243.
21. Tanaka S, Kimura Y, Furukawa M. Pseudoaneurysm of the carotid artery with haemorrhage into the hypopharynx. J Laryngol Otol 1995; 109: 889-891.
22. Dorresteijn LD, Rappelle AC, Boogerd W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 2002; 20: 282-288.
23. Moritz MW, Higgins RF, Jacobs JR. Duplex imaging and incidence of carotid radiation injury after high-dose radiotherapy for tumors of the head and neck. Arch Surg 1990; 125: 1181-1183.
24. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003; 290: 2831-2837.
25. Behringer K, Josting A, Schiller P, et al. Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol 2004; 15: 1079-1085.
26. Keresztes K, Miltényi Zs, András Cs, Illés Á. Második malignus tumor gondozott Hodgkin-kóros betgeinknél. Magy Onkol 2002; 46: 247-251.
27. Hoppe RT. Long-term complications of treatment for Hodgkin's disease. Trends Onco-hematol 1996; 4: 46-48.
28. Diamond MS, Levi M. Renal and genitourinary complications from the treatment of Hodgkin's disease. In Hodgkin's Disease: The Consequenses of Survival (1st edn). Lacher JM, Redman JR (eds). Lea and Febiger Ltd: Philadelphia, London, 1990; 306-313.
29. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Fertility after treatment for Hodgkin's disease. Ann Oncol 2002; 13: 138-147.
30. Zimbalist E, Shike M. Gastrointestinal complications of staging and treatment of Hodgkin's disease. In Hodgkin's Disease: The Consequenses of Survival (1st edn). Lacher JM, Redman JR (eds). Lea and Febiger Ltd: Philadelphia, London, 1990; 316-330.